Detalhe da pesquisa
1.
Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic.
Gut
; 72(2): 295-305, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902214
2.
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD.
Gut
; 70(10): 1884-1893, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903149
3.
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
Gut
; 70(5): 865-875, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753421
4.
Impact of thiopurines and anti-tumour necrosis factor therapy on hospitalisation and long-term surgical outcomes in ulcerative colitis.
World J Gastrointest Surg
; 7(12): 360-9, 2015 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26730281